English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/103073
Compartir / Impacto:
Estadísticas
Add this article to your Mendeley library MendeleyBASE
Citado 2 veces en Web of Knowledge®  |  Pub MebCentral Ver citas en PubMed Central  |  Ver citas en Google académico
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar otros formatos: Exportar EndNote (RIS)Exportar EndNote (RIS)Exportar EndNote (RIS)
Título

A sequential procedure for rapid and accurate identification of putative trichomonacidal agents

Autor Ibáñez-Escribano, Alexandra; Meneses-Marcel, Alfredo; Marrero-Ponce, Yovani; Nogal-Ruiz, Juan José; Arán, Vicente J. ; Gómez-Barrio, Alicia; Escario, José Antonio
Palabras clave In vitro
In vivo
QSAR
Trichomonas vaginalis
TOMOCOMD-CARDD
Fecha de publicación 2014
EditorElsevier
Citación Journal of Microbiological Methods 105: 162- 167 (2014)
ResumenIn the current report, a sequential step-wise methodology based on in silico, in vitro and in vivo experimental procedures for the prompt detection of potential trichomonacidal drugs is proposed. A combinatorial of 12 QSAR (Quantitative Structure-Activity Relationship) models based on Linear Discrimination Analysis (LDA) are suggested for the rational identification of new trichomonacidal drugs from virtual screening of in house chemical libraries and drug databases. Subsequently, compounds selected as potential anti-trichomonas are screened in vitro against Trichomonas vaginalis. Finally, molecules with specific trichomonacidal activity are evaluated in vivo. Herein, different molecules were exposed to the proposed methodology. Firstly, the agents were virtually screened and two of the eight molecules (G-1 and dimetridazole) were classified as trichomonacidals by the 12 models. Subsequently both drugs were proved in vitro and in vivo following the workflow procedure. Although a remarkable in vitro activity was observed in both cases, dimetridazole achieved higher MIC100 activity than metronidazole against the resistant isolate. Furthermore, the in vivo models showed a remarkable reduction of lesions of more than 55% in both compounds. These observations support the current flowchart screening and suggest the use of dimetridazole as a promising drug-like scaffold for novel therapeutic alternatives against T. vaginalis resistant infections.
URI http://hdl.handle.net/10261/103073
DOI10.1016/j.mimet.2014.07.031
Identificadoresdoi: 10.1016/j.mimet.2014.07.031
issn: 0167-7012
e-issn: 1872-8359
Aparece en las colecciones: (IQM) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo
 



NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.